JONATHAN WILLIAMS: Open Payments
NPI 1821253683 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 42 payments from 15 companies in 2025. Trend: 2023 $753 · 2024 $768 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $146 |
| Insulet Corporation | 4 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 4 | $62 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| Ascendis Pharma Endocrinology Inc | 3 | $49 |
| Novo Nordisk Inc | 3 | $46 |
| Abbott Laboratories | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Madrigal Pharmaceuticals | 2 | $37 |
Products named: MOUNJARO, Omnipod, JARDIANCE, LEQVIO, CRENESSITY, FREESTYLE LIBRE 3, RECORLEV, REZDIFFRA.
Industry payments across ID — which companies pay providers there.
